Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Highly multiplexed spatial analysis identifies tissue-resident memory T cells as drivers of ulcerative and immune checkpoint inhibitor colitis.
van Eijs MJM, Ter Linde JJM, Baars MJD, Amini M, Laclé MM, Brand EC, Delemarre EM, Drylewicz J, Nierkens S, Verheijden RJ, Oldenburg B, Vercoulen Y, Suijkerbuijk KPM, van Wijk F. van Eijs MJM, et al. iScience. 2023 Sep 11;26(10):107891. doi: 10.1016/j.isci.2023.107891. eCollection 2023 Oct 20. iScience. 2023. PMID: 37766980 Free PMC article.
Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies.
Van Not OJ, van den Eertwegh AJM, Haanen JB, van Rijn RS, Aarts MJB, van den Berkmortel FWPJ, Blank CU, Boers-Sonderen MJ, van Eijs MJM, de Groot JB, Hospers GAP, Kapiteijn E, de Meza M, Piersma D, Stevense-den Boer M, van der Veldt AAM, Vreugdenhil G, Wouters MWJM, Suijkerbuijk KPM, Blokx WAM. Van Not OJ, et al. Among authors: van eijs mjm. Eur J Cancer. 2023 Jun;186:27-37. doi: 10.1016/j.ejca.2023.03.009. Epub 2023 Mar 16. Eur J Cancer. 2023. PMID: 37023588 Free article.
Hematologic malignancies following immune checkpoint inhibition for solid tumors.
van Eijs MJM, van der Wagen LE, Mous R, Leguit RJ, van de Corput L, van Lindert ASR, Suelmann BBM, Kamphuis AM, Nierkens S, Suijkerbuijk KPM. van Eijs MJM, et al. Cancer Immunol Immunother. 2023 Jan;72(1):249-255. doi: 10.1007/s00262-022-03230-4. Epub 2022 Jun 13. Cancer Immunol Immunother. 2023. PMID: 35691988 Free PMC article.